HONG KONG YASHI BIOTECHNOLOGY LIMITED – Trademark Portfolio

Entity Type: 99

HONG KONG YASHI BIOTECHNOLOGY LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include WARITO and WEOISC. The owner is based in HONG KONG.

RM 22, 2ND FLOOR, FU DU BLDG

98 ARGYLE STREET, MONG KOK, KOWLOON

HONG KONG 999077 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WARITO
WARITO
Registered 2020
WEOISC
WEOISC
Registered 2020

Trademark Classifications

HONG KONG YASHI BIOTECHNOLOGY LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does HONG KONG YASHI BIOTECHNOLOGY LIMITED have?

HONG KONG YASHI BIOTECHNOLOGY LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does HONG KONG YASHI BIOTECHNOLOGY LIMITED file in?

HONG KONG YASHI BIOTECHNOLOGY LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HONG KONG YASHI BIOTECHNOLOGY LIMITED's most well-known trademarks?

HONG KONG YASHI BIOTECHNOLOGY LIMITED's registered trademark portfolio includes well-known marks such as WARITO and WEOISC. These are among 2 currently registered trademarks in the portfolio.

What is HONG KONG YASHI BIOTECHNOLOGY LIMITED's trademark registration success rate?

HONG KONG YASHI BIOTECHNOLOGY LIMITED has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.